## Abstract Screening for prostate cancer using prostate‐specific antigen (PSA) tests has led to a stage and grade shift as compared to the pre‐PSA era. Effectiveness of screening for prostate cancer should be manifested by a reduction in detection rate of aggressive cancers during subsequent scree
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
✍ Scribed by S.J. Otto; S.M. Moss; L. Määttänen; M. Roobol; M. Zappa; V. Nelen; M. Kwiatkowski; A. Villers; J. Hugosson; A. Berenguer Sanchez; H.J. de Koning
- Book ID
- 116430546
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 230 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni
## Abstract The extent of effective prostate‐specific antigen (PSA) contamination in the Rotterdam section of the ongoing European Randomized Study of Screening for Prostate Cancer (ERSPC) trial was evaluated and defined as when opportunistic PSA testing of ≥ 3.0 ng/ml was followed by biopsy, simil